HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $58,000 | -27.5% | 361,415 | -18.7% | 0.00% | – |
| Q4 2018 | $80,000 | -27.3% | 444,640 | -7.3% | 0.00% | – |
| Q3 2018 | $110,000 | -26.7% | 479,679 | +2.6% | 0.00% | – |
| Q2 2018 | $150,000 | -15.7% | 467,574 | +3.6% | 0.00% | – |
| Q1 2018 | $178,000 | +74.5% | 451,169 | +53.2% | 0.00% | – |
| Q4 2017 | $102,000 | -34.6% | 294,489 | -39.1% | 0.00% | – |
| Q3 2017 | $156,000 | -31.3% | 483,873 | +6.6% | 0.00% | – |
| Q2 2017 | $227,000 | -7.7% | 453,805 | +0.6% | 0.00% | – |
| Q1 2017 | $246,000 | -16.9% | 451,096 | +5.0% | 0.00% | – |
| Q4 2016 | $296,000 | -49.1% | 429,697 | -7.4% | 0.00% | – |
| Q3 2016 | $581,000 | – | 464,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,938,374 | $620,000 | 0.10% |
| Occidental Asset Management, LLC | 15,834 | $5,000 | 0.00% |
| Waldron Private Wealth LLC | 11,000 | $3,000 | 0.00% |
| VANGUARD GROUP INC | 467,574 | $150,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
| UBS Group AG | 20,658 | $7,000 | 0.00% |
| Advisor Group, Inc. | 250 | $0 | 0.00% |
| Jacobi Capital Management LLC | 318 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 2,501 | $0 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |